1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. PDGFR
  4. PDGFR Inhibitors

PDGFR Inhibitors

PDGFR

PDGFRβ

PDGFRα

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PDGFR Inhibitors & Modulators
Product Name PDGFR PDGFRβ PDGFRα Purity
Lenvatinib  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
99.85%
Nintedanib  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.94%
Regorafenib  
PDGFRβ, IC50: 22 nM
  99.93%
Sunitinib  
PDGFRβ, IC50: 2 nM
  99.04%
Multi-kinase inhibitor 3  
PDGFR-β, IC50: 1.15 nM
PDGFRα, IC50: 0.22 nM
WQ-C-401  
PDGFRβ, EC50: 5.8 nM
PDGFRα, EC50: 3.5 nM
Ponatinib    
PDGFRα, IC50: 1.1 nM
99.67%
Axitinib  
PDGFRβ, IC50: 1.6 nM
  99.94%
Pazopanib  
PDGFRβ, IC50: 84 nM
  99.91%
SU 5402  
PDGFRβ, IC50: 510 nM
  99.86%
Nintedanib esylate  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.96%
Lenvatinib mesylate  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
99.86%
CP-673451  
PDGFRβ, IC50: 1 nM
PDGFRα, IC50: 10 nM
99.69%
Crenolanib  
PDGFRβ, Kd: 3.2 nM
PDGFRα, Kd: 2.1 nM
99.68%
Sunitinib Malate  
PDGFRβ, IC50: 2 nM
  99.86%
Ripretinib    
PDGFRA
98.90%
Linifanib  
PDGFRβ, IC50: 66 nM
  99.28%
Cediranib  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
99.58%
Dovitinib  
PDGFRβ, IC50: 27 nM
PDGFRα, IC50: 210 nM
99.88%
Pazopanib Hydrochloride  
PDGFRβ, IC50: 84 nM
  99.99%
CHIR-124
PDGFR, IC50: 6.6 nM
    99.05%
Regorafenib monohydrate  
PDGFRβ, IC50: 22 nM
  99.96%
Ponatinib hydrochloride    
PDGFRα, IC50: 1.1 nM
99.55%
Regorafenib Hydrochloride  
PDGFRβ, IC50: 22 nM
  99.58%
Amuvatinib    
PDGFRαV561D, IC50: 40 nM
PDGFRαD842V, IC50: 81 nM
99.47%
M4205  
PDGFRβ, IC50: 2.6 nM
PDGFRA, IC50: 50 nM
99.47%
SU14813  
PDGFRβ, IC50: 4 nM
  99.63%
Orantinib  
PDGFRβ, Ki: 8 nM
  99.21%
PP121
PDGFR, IC50: 2 nM
    98.67%
Tyrphostin AG1296  
PDGFRβ
PDGFRα
99.69%
Telatinib    
PDGFRα, IC50: 15 nM
99.37%
Ilorasertib hydrochloride  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
98.48%
ENMD-2076    
PDGFRα, IC50: 56.4 nM
99.99%
TAK-593  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 4.3 nM
PDGFRαV561D, IC50: 1 nM
99.66%
JNJ-10198409  
PDGFRβ, IC50: 4.2 nM
PDGFRα, IC50: 45 nM
99.57%
PP58
PDGFR
    99.75%
Toceranib  
PDGFRβ, Ki: 5 nM
 
SU16f
PDGFR2, IC50: 140 nM
PDGFR1, IC50: 2.29 μM
PDGFRβ, IC50: 10 nM
  99.36%
Tandutinib
PDGFR, IC50: 0.2 μM
    99.48%
Methylnissolin
PDGFR, IC50: 10 μM
    99.86%
SU4312
PDGFR
    99.76%
Seralutinib  
PDGFRβ
PDGFRα
99.94%
Famitinib  
PDGFRβ, IC50: 6.6 nM
  98.43%
Cediranib maleate  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
99.95%
Toceranib phosphate  
PDGFRβ, Ki: 5 nM
  98.54%
PD-161570
PDGFR, IC50: 310 nM
PDGFRβ, IC50: 262 nM
  99.82%
PDGFRα kinase inhibitor 1  
PDGFRβ, IC50: 6115 nM
PDGFRα, IC50: 132 nM
99.78%
Chiauranib  
PDGFRβ, IC50: 93 nM
PDGFRα, IC50: 1 nM
99.28%
SU14813 maleate  
PDGFRβ, IC50: 4 nM
  99.04%
JI-101  
PDGFRβ
  99.78%
TG 100572 Hydrochloride  
PDGFRβ, IC50: 13 nM
  98.96%
Tovetumab    
PDGFRα
99.49%
TG 100801  
PDGFRβ, IC50: 13 nM
  98.61%
Zeteletinib
PDGFR2
    98.31%
ENMD-2076 Tartrate    
PDGFRα, IC50: 56.4 nM
99.42%
Ilorasertib  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
99.86%
Dovitinib lactate  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
99.75%
Multi-kinase inhibitor 1
PDGFR
    99.34%
Flumatinib mesylate  
PDGFRβ, IC50: 307.6 nM
  99.80%
Tandutinib hydrochloride
PDGFR, IC50: 0.2 μM
    99.78%
PD-089828  
PDGFR-β, IC50: 1.76 μM
PDGFR-β, Ki: 2.38 μM
  98.07%
PDGFRα kinase inhibitor 2
PDGFR, IC50: 1.39 μM
    98.95%
AC710  
PDGFRβ, Kd: 1 nM
PDGFRα, Kd: 1.3 nM
99.13%
AZD2932  
PDGFRβ, IC50: 4 nM
  99.04%
(Z)-Orantinib  
PDGFRβ, IC50: 0.008 μM
  99.44%
AXL-IN-13  
PDGFRβ, Kd: 2.3 nM
  98.03%
HG-7-85-01    
PDGFRα, IC50: 440 nM
99.94%
Tyrphostin AG1433  
PDGFRβ, IC50: 5 μM
  99.08%
NVP-ACC789  
PDGFR-β, IC50: 1.4 μM
  99.52%
Hypothemycin  
PDGFRβ, Ki: 900 nM
PDGFRα, Ki: 1.5 μM
≥98.0%
XL 999    
PDGFRα, IC50: 4 nM
99.01%
Telatinib mesylate    
PDGFRα, IC50: 15 nM
99.74%
GZD856 formic  
PDGFRβ, IC50: 136.6 nM
PDGFRα, IC50: 68.6 nM
98.06%
KG5  
PDGFRβ, Kd: 520 nM
PDGFRα, Kd: 300 nM
99.79%
AG 370
PDGFR, IC50: 20 μM
   
BMS-605541  
PDGFR-β, IC50: 200 nM
  99.57%
Sunitinib-d10  
PDGFRβ, IC50: 2 nM
  99.89%
Ponatinib-d8    
PDGFRα, IC50: 1.1 nM
99.91%
TG 100572  
PDGFRβ, IC50: 13 nM
 
Dovitinib lactate hydrate  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
Regorafenib mesylate  
PDGFRβ, IC50: 22 ± 3 nM
 
GZD856  
PDGFRβ, IC50: 136.6 nM
PDGFRα, IC50: 68.6 nM
Amuvatinib hydrochloride    
PDGFRαV561D, IC50: 40 nM
PDGFRαD842V, IC50: 81 nM
Zeteletinib hemiadipate
PDGFR2
   
Famitinib malate  
PDGFRβ, IC50: 6.6 nM
 
SU 5402 (GMP)  
PDGFRβ, IC50: 510 nM
 
Multi-kinase-IN-1    
PDGFRα, IC50: 0.384 μM
Ki11502  
PDGFRβ, IC50: <10 nM
PDGFRα, IC50: <10 nM
99.30%
Multi-kinase inhibitor 4  
PDGFRβ, IC50: 0.89 nM
PDGFRα, IC50: 0.18 nM
HSN748  
PDGFRβ
PDGFRα
SA-PA  
PDGFR-β
 
Multi-kinase-IN-2  
PDGFRβ, IC50: 9.9 ± 0.7 nM
PDGFRα, IC50: 7.0 ± 0.1 nM
Multi-kinase-IN-3  
PDGFRβ, IC50: 55 ± 2.6 nM
 
Multi-kinase-IN-5
PDGFR
   
IHMT-TRK-284  
PDGFRβ, IC50: 95.7 nM
PDGFRα, IC50: 24.2 nM
Henatinib  
PDGFRβ
PDGFRα
TG 100801 Hydrochloride  
PDGFRβ, IC50: 13 nM
 
VEGFR-2-IN-44  
PDGFR-β, IC50: 920 nM
 
SU-4313
PDGFR, IC50: 14.5 μM
    99.31%
AC710 Mesylate  
PDGFRβ, Kd: 1 nM
PDGFRα, Kd: 1.3 nM